Press Releases
Press Releases
More Press Releases
View Older Stories View Newer Stories-
Indeed Partners with Udemy to Empower Job Seekers with In-Demand Skills
-
Nav Names Doe Gregersen as General Counsel
-
DVCon U.S. 2026 Announces Call for Extended Abstracts, Workshop and Tutorial Proposals
-
A New Era Begins: PMSI Announces Strategic Board Member Appointments
-
SGNL Launches MCP Gateway to Enable Secure AI Adoption for Enterprise Workforces
-
GigaDevice Anchors Global Headquarters in Singapore to Power Synergy and Impact
-
LambdaTest Integrates with Assembla to Streamline Bug Tracking for Development Teams
-
Dean Omar Branham Shirley Named Finalist for Product Liability Practice Award
-
Bondex’s Native Utility Token $BDXN Listed on Kraken and Bybit
-
Trace3 Accelerates Coast-to-Coast Growth With Acquisition of IVOXY
-
Bondex’s Native Utility Token $BDXN Listed on Kraken and Bybit
-
New Self-Help Book SKIN DEEP Considers the Advancements, Challenges and Opportunities of Modern Skin Care Practices and Puts Power Back in the Hands of Patients
-
SUCCESS® Magazine’s Business Of Sports Issue Hits Newsstands
-
CoreStack and Archera Partner to Turn Cloud Optimization Into a Growth Engine
-
Logo Brands Acquires FanMats, Expanding Its Footprint Into Home, Garage, and Lifestyle Categories
-
MTM Health Celebrates 30 Years of Improving Health Outcomes Nationwide
-
University of Phoenix and University of Idaho Conclude Affiliation Discussions
-
TOPDON US Grows Retail Presence Across the Country Through Bass Pro Shops, West Marine, AutoZone, Big 5 Sporting Goods and Tractor Supply
-
Canada Growth Fund announces additional investment in Eavor Technologies, a Calgary-based advanced geothermal technology company
-
Hyundai Motor Company President and CEO José Muñoz Reinforces Hyundai's Journey as a Mobility Leader at FISITA World Mobility Conference 2025
-
Sky Ranch Celebrates 70 Years of Life-Changing Experiences, Unplugged Adventures, and Christ-Centered Growth
-
IOVA Investors Have the Opportunity to Lead the Iovance Biotherapeutics Securities Fraud Lawsuit with Faruqi & Faruqi, LLP
-
Healthie Launches Dev Assist: AI-Native Tooling for Rapid Healthcare App Development, Powered by the Model Context Protocol (MCP)
-
CryptoNewsBreaks – SolarBank Corporation (NASDAQ: SUUN) (Cboe CA: SUNN) (FSE: GY2) Adopts Bitcoin Treasury Strategy to Strengthen Financial and Market Position
-
Sports Illustrated Stadium Will Host Inaugural Concert Series This October With Country Superstar Jason Aldean, Hip-Hop Icon Ludacris and More Over Two Consecutive Nights
-
NB Private Equity Partners Limited Total Voting Rights
-
Amplify ETFs Bitcoin Option Income ETFs Declare First Income Distributions
-
New Rislone DEF Treatment Super Concentrate Keeps Diesel Exhaust Fluid Crystal-Free and Boosts Performance
-
Blue Cross and Blue Shield of Louisiana to Cover Kerecis Fish Skin Grafts for Diabetic Foot Ulcers
-
Lutheran Family and Children’s Services Issues “Meet the Moment” Appeal As Missouri Nonprofits Face “Quiet Crisis” Amid Rising Demand
-
URGN Investors Have the Opportunity to Lead the UroGen Securities Fraud Lawsuit with Faruqi & Faruqi, LLP
-
InvestorNewsBreaks – Standard Lithium Ltd. (NYSE American: SLI) Produces Battery-Grade Lithium Sulfide in Collaboration with Telescope Innovations
-
Holland America Line Builds on Northern Europe Expertise with Third Dedicated Ship Exploring the Region in 2027
-
Wyr.ai Partners with Vuzix to Launch Its New M400 Smart Glasses-based AI-driven Quality Assurance Inspection Platform
-
DARZALEX FASPRO® (daratumumab and hyaluronidase-fihj)-based regimen shows 95 percent progression-free survival at four years in transplant-eligible, newly diagnosed patients with multiple myeloma who
-
Single infusion of CARVYKTI® (ciltacabtagene autoleucel) delivered lasting treatment-free remissions for at least five years in patients with relapsed or refractory multiple myeloma
-
Early results from Johnson & Johnson's trispecific antibody show promising response in heavily pretreated multiple myeloma patients
-
Legend Biotech Unveils Groundbreaking 5-Year Survival Data for CARVYKTI® in Multiple Myeloma at 2025 ASCO Annual Meeting
-
NPWR Investors Have the Opportunity to Lead the NET Power Fraud Lawsuit with Faruqi & Faruqi, LLP
-
DNUT Investors Have the Opportunity to Lead the Krispy Kreme Securities Fraud Lawsuit with Faruqi & Faruqi, LLP
-
PAIRMiner Launches Cloud Mining Platform Supporting Bitcoin and Dogecoin
-
Tims China Registration & Webcast details for Q1 2025 Results Conference Call on June 24, 2025
-
Middlefield Canadian Income PCC: Net Asset Value(s)
-
Tims China Registration & Webcast details for Q1 2025 Results Conference Call on June 24, 2025
-
Vital Wound Care Launches AI-Driven Wound App and Expands In-Home Services Across Greater Houston
-
The Future of AI in the AEC Industry Unveiled at BST Global’s 2025 AI Summit
-
ZBIO Investors Have the Opportunity to Lead the Zenas BioPharma Securities Fraud Lawsuit with Faruqi & Faruqi, LLP
-
Marlton Partners Calls on 180 Degree Capital Corp. to Set Record Date Now and Allow Shareholders to Determine Company's Future
-
PensionBee Analysis Finds Left-Behind 401ks May Cost Americans $90,000 by Retirement
-
Hold Onto Your Cocktail: Captain Morgan and Universal Pictures' M3GAN 2.0 Join Forces with a Glow-in-the-Dark Spiced Rum Bottle and Limited-Edition Cocktail Experience
